![Debjani Singh](/sites/default/files/styles/featured_square_large/public/2024-08/2024-P12408.jpg?h=8f9cfe54&itok=bP5F6U4Y)
Filter News
Area of Research
- Biological Systems (1)
- Biology and Environment (17)
- Clean Energy (11)
- Computational Biology (2)
- Computational Engineering (1)
- Fusion and Fission (3)
- Isotope Development and Production (1)
- Isotopes (7)
- Materials (9)
- Materials for Computing (3)
- National Security (12)
- Neutron Science (13)
- Nuclear Science and Technology (2)
- Sensors and Controls (1)
- Supercomputing (21)
News Topics
- (-) Biomedical (60)
- (-) Irradiation (3)
- (-) Security (25)
- 3-D Printing/Advanced Manufacturing (125)
- Advanced Reactors (34)
- Artificial Intelligence (97)
- Big Data (60)
- Bioenergy (92)
- Biology (100)
- Biotechnology (23)
- Buildings (61)
- Chemical Sciences (70)
- Clean Water (31)
- Climate Change (104)
- Composites (29)
- Computer Science (195)
- Coronavirus (46)
- Critical Materials (29)
- Cybersecurity (35)
- Decarbonization (82)
- Education (4)
- Element Discovery (1)
- Emergency (2)
- Energy Storage (112)
- Environment (198)
- Exascale Computing (40)
- Fossil Energy (6)
- Frontier (44)
- Fusion (57)
- Grid (66)
- High-Performance Computing (90)
- Hydropower (11)
- Isotopes (55)
- ITER (7)
- Machine Learning (49)
- Materials (145)
- Materials Science (145)
- Mathematics (9)
- Mercury (12)
- Microelectronics (4)
- Microscopy (51)
- Molten Salt (8)
- Nanotechnology (60)
- National Security (71)
- Net Zero (14)
- Neutron Science (134)
- Nuclear Energy (110)
- Partnerships (49)
- Physics (63)
- Polymers (33)
- Quantum Computing (37)
- Quantum Science (71)
- Renewable Energy (2)
- Simulation (49)
- Software (1)
- Space Exploration (25)
- Statistics (3)
- Summit (59)
- Sustainable Energy (130)
- Transformational Challenge Reactor (7)
- Transportation (97)
Media Contacts
![ATOM logo](/sites/default/files/styles/list_page_thumbnail/public/2021-03/ATOM_Logo_small.png?h=8f9cfe54&itok=Qpezfk8V)
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.
![Targeted alpha therapy can deliver radiation to specific cells, with minimal effect on surrounding, healthy cells. Credit: Michelle Lehman and Jaimee Janiga/ORNL, U.S. Dept. of Energy](/sites/default/files/2021-03/gif_high_res.gif)
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.
![Neutron scattering experiments show electric charges, shown in red, blue and grey, in the SARS-CoV-2 main protease site where telaprevir binds to the structure. The experiments provide critical data for the design of small-molecule drugs to treat COVID-19. Credit: Jill Hemman and Michelle Lehman/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-03/after_transprent_background-wFill.png?h=c71d0c67&itok=jGFt_Ggj)
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.
![Verónica Melesse Vergara speaks with third and fourth graders at East Side Intermediate School in Brownsville. Credit: ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-02/EWeek_vergara_0.jpg?h=c44fcfa1&itok=-FdYpHed)
Twenty-seven ORNL researchers Zoomed into 11 middle schools across Tennessee during the annual Engineers Week in February. East Tennessee schools throughout Oak Ridge and Roane, Sevier, Blount and Loudon counties participated, with three West Tennessee schools joining in.
![ORNL recognized the small businesses that have made a positive impact on ORNL’s operations at the virtual 2020 Small Business Awards. Credit: ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2020-11/2013-P05160-cropped_0.jpg?h=8f74817f&itok=VU4aJf_i)
Thirty-two Oak Ridge National Laboratory employees were named among teams recognized by former DOE Secretary Dan Brouillette with Secretary’s Honor Awards as he completed his term. Four teams received new awards that reflect DOE responses to the coronavirus pandemic.
Oak Ridge National Laboratory and collaborators have discovered that signaling molecules known to trigger symbiosis between plants and soil bacteria are also used by almost all fungi as chemical signals to communicate with each other.
![Frontier supercomputer](/sites/default/files/styles/list_page_thumbnail/public/2023-01/frontier_0.jpg?h=a1e1a043&itok=J3IM_Xeh)
A multi-institutional team, led by a group of investigators at Oak Ridge National Laboratory, has been studying various SARS-CoV-2 protein targets, including the virus’s main protease. The feat has earned the team a finalist nomination for the Association of Computing Machinery, or ACM, Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research.
![coronavirus](/sites/default/files/styles/list_page_thumbnail/public/2020-11/coronavirus_top10%20%28002%29.png?h=997b30da&itok=7I6TjG_l)
NellOne Therapeutics has licensed a drug delivery system from the Department of Energy’s Oak Ridge National Laboratory that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19.
![ORNL assisted in investigating proteins called porins, one shown in red, which are found in the protective outer membrane of certain disease-causing bacteria and tether the membrane to the cell wall. Credit: Hyea (Sunny) Hwang/Georgia Tech and ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2020-11/Biology-gram-negative_0.jpg?h=ced0ee1c&itok=mTOudglI)
Scientists from Oak Ridge National Laboratory used high-performance computing to create protein models that helped reveal how the outer membrane is tethered to the cell membrane in certain bacteria.
![Sandra Davern performs cell based assays to evaluate cell death and DNA damage in response to radiation in order to gain a better understanding of how radioisotope nanoparticles affect the human body.](/sites/default/files/styles/list_page_thumbnail/public/2020-10/2020-P15712.jpg?h=036a71b7&itok=6cpxN4v2)
When Sandra Davern looks to the future, she sees individualized isotopes sent into the body with a specific target: cancer cells.